India's decentralised vaccine policy is a recipe for inequality
India's messy vaccination strategy, unlike any other in the world, is now pitting its own states against each other.
After the Narendra Modi government announced a "liberalised" policy on April 19, Indian states can now directly buy Covid-19 vaccines from manufacturers. In the face of an acute shortage of doses of Covisheild and Covaxin, the two India-made vaccines currently approved for emergency use, some state governments have now floated "global tenders" shots.
